P&G stannous fluoride analysis suggested as gingivitis efficacy model by plaque subcmte.
This article was originally published in The Rose Sheet
Executive Summary
P&G FLUORIDE ANALYSIS AS "MODUS OPERANDI" SUGGESTED BY PLAQUE SUBCMTE. for other companies to follow in the quest to prove ingredient efficacy for plaque, gingivitis and gingival bleeding claims. Procter & Gamble's analyses of the efficacy of stannous fluoride at the Dec. 16-17 meeting of the Dental Product Panel's Plaque Subcommittee may serve as an "umbrella" model that, "while not definitive for every product," may provide "a general modus operandi" for other ingredients seeking to claim prevention and reduction of gingivitis, Subcommittee Chair Robert Genco, PhD, SUNY-Buffalo School of Medicine, said.